Christopherson W M, Gray L A, Parker J E
Cancer. 1976 Aug;38(2):629-32. doi: 10.1002/1097-0142(197608)38:2<629::aid-cncr2820380202>3.0.co;2-e.
One hundred and eleven patients with microinvasive carcinoma of the uterine cervix were studied over a 21-year period. Thirty-five cases of carcinoma in situ with questionable stromal invasion were excluded. Cases with pathologic examination of less than a cervical cone or the entire cervix were not accepted. The sole pathologic criterion for inclusion was unequivocal invasion to a depth of no more than 5.0 mm. Ninety-one patients were followed for 5 years or until death, and 80 patients for 10 years or until death. One patient was lost to follow-up at 5.5 years. The two deaths officially attributed to cervix cancer prior to 10 years were signed out by nonphysician assistant coroners. Available clinical evidence indicates that at least one of these patients, and probably both, did not die of cervix cancer. From these data, simple hysterectomy would seem to be the maximal treatment indicated. Since the prognosis of microinvasive carcinoma is similar to that of carcinoma in situ, it is suggested that such cases not be included when considering the end results of Stage I cervix cancer.
在21年的时间里,对111例宫颈微浸润癌患者进行了研究。排除了35例原位癌伴可疑间质浸润的病例。病理检查少于宫颈锥切或整个宫颈的病例不被纳入。纳入的唯一病理标准是明确浸润深度不超过5.0毫米。91例患者随访5年或直至死亡,80例患者随访10年或直至死亡。1例患者在5.5年时失访。10年前官方归因于宫颈癌的2例死亡由非医生助理验尸官签字确认。现有的临床证据表明,这些患者中至少有1例,可能2例都不是死于宫颈癌。根据这些数据,单纯子宫切除术似乎是所指示的最大治疗方法。由于微浸润癌的预后与原位癌相似,因此建议在考虑I期宫颈癌的最终结果时不包括此类病例。